
Challenge: Bloom Science needed to explain a highly technical clinical trial in a way that was clear, credible, and newsworthy for national, regional, and health reporters.
Strategy: On The Marc Media positioned the trial as a timely obesity innovation story, focusing on the growing demand for new, science-backed options beyond GLP-1 medications.
Execution: We developed targeted media messaging, refined reporter-friendly pitches, and prepared Bloom’s team to clearly communicate the science, safety, and market opportunity behind the trial.
Result: The campaign helped turn a complex clinical trial announcement into a newsworthy story that got widespread media coverage and positioned Bloom Science’s BL-001 program within the larger obesity innovation conversation.
*By downloading the Insight, The Art of Tweeting you are also joining our newsletter.












